APLM Stock Analysis: Buy, Sell, or Hold?
$23.00
2.50 (12.20%)
▲
5d:
+64.76%
30d:
+63.24%
90d:
+24.39%
WAIT
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Jul 24, 2026
28d
Get Alerted When APLM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: APLM is 26.7% above its trading range ($18.15). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: APLM is 26.7% above its trading range ($18.15). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: APLM is currently trading at $23.00, which is considered extended relative to its 30-day fair value range of $12.55 to $18.15.
Technical Outlook: Technically, APLM is in a strong downtrend. The price is approaching resistance at $22.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 12.2% recently.
Market Sentiment: APLM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APLM is in a strong downtrend. The price is approaching resistance at $22.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 12.2% recently.
Market Sentiment: APLM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$12.55 -
$18.15
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+26.7% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.2%)
- BEARISH: Trading 90.2% above Wall St target ($2.00)
- WARNING: Recommendation downgraded due to 26.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$12.55 -
$18.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$12.88
Resistance Level
$22.88
Current Trend
Strong Downtrend
Technical data as of
Jun 24, 2026
Fundamental Context
Wall Street Target
$2.00
(-90.2%)
Revenue Growth (YoY)
380.8%
Profit Margin
-123.7%
Share & Embed Analysis
Last updated: June 25, 2026 10:36 AM ET
Data refreshes hourly during market hours. Next update: 11:36 AM
Data refreshes hourly during market hours. Next update: 11:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APLM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 57 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
12 analysts |
$139 | 63 BUY |